The 10 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 14.00. The median estimate represents a +89.31% increase from the last price of 8.98.
The current consensus among 10 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.41
Reporting Date Mar 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.